Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.67B |
| 2 |
United Parcel Service
UPS
|
+$94.2M |
| 3 |
FedEx
FDX
|
+$93.1M |
| 4 |
Union Pacific
UNP
|
+$90.2M |
| 5 |
Invesco MSCI USA ETF
PBUS
|
+$89.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$144M |
| 2 |
Spotify
SPOT
|
+$84.9M |
| 3 |
Vertiv
VRT
|
+$61.6M |
| 4 |
C.H. Robinson
CHRW
|
+$57.4M |
| 5 |
Core & Main
CNM
|
+$56.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.44% |
| 2 | Industrials | 11.5% |
| 3 | Consumer Discretionary | 8.61% |
| 4 | Healthcare | 6.52% |
| 5 | Financials | 4.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Carnival Corporation Ltd
CCL
$35.8B
| $733K | ﹤0.01% |
+29,428
| New | +$689K |
|
1252
Amylyx Pharmaceuticals
AMLX
$4.17B
| $733K | ﹤0.01% |
193,931
+27,502
| +17% | +$129K |
|
1253
Expro Ltd
XPRO
$1.98B
| $732K | ﹤0.01% |
+58,734
| New | +$818K |
|
1254
Insight Enterprises
NSIT
$4.42B
| $732K | ﹤0.01% |
+4,814
| New | +$860K |
|
1255
Charles River Laboratories
CRL
$14.2B
| $732K | ﹤0.01% |
3,963
+152
| +4% | +$29.3K |
|
1256
BioMarin Pharmaceuticals
BMRN
$12.8B
| $730K | ﹤0.01% |
11,100
-19,548
| -64% | -$1.31M |
|
1257
Doximity
DOCS
$4.41B
| $726K | ﹤0.01% |
+13,600
| New | +$666K |
|
1258
UroGen Pharma
URGN
$2.27B
| $725K | ﹤0.01% |
68,100
-56,200
| -45% | -$673K |
|
1259
Silgan Holdings
SLGN
$4.51B
| $724K | ﹤0.01% |
+13,911
| New | +$742K |
|
1260
American Healthcare REIT
AHR
$12.4B
| $722K | ﹤0.01% |
25,400
-27,300
| -52% | -$734K |
|
1261
iQIYI
IQ
$994M
| $721K | ﹤0.01% |
+358,927
| New | +$850K |
|
1262
Liberty Global Class A
LBTYA
$3.68B
| $715K | ﹤0.01% |
56,056
+18,156
| +48% | +$303K |
|
1263
NatWest
NWG
$74.9B
| $715K | ﹤0.01% |
70,267
+42,567
| +154% | +$421K |
|
1264
New Jersey Resources
NJR
$5.46B
| $714K | ﹤0.01% |
15,300
+6,569
| +75% | +$311K |
|
1265
Mirum Pharmaceuticals
MIRM
$5.98B
| $711K | ﹤0.01% |
17,200
+487
| +3% | +$20.3K |
|
1266
O-I Glass
OI
$1.15B
| $711K | ﹤0.01% |
65,596
-605,405
| -90% | -$7.36M |
|
1267
Harley-Davidson
HOG
$2.86B
| $709K | ﹤0.01% |
23,541
-15,701
| -40% | -$520K |
|
1268
Primoris Services
PRIM
$4.03B
| $706K | ﹤0.01% |
9,247
-15,558
| -63% | -$1.14M |
|
1269
Manchester United
MANU
$4.12B
| $706K | ﹤0.01% |
+40,706
| New | +$687K |
|
1270
Mid-America Apartment Communities
MAA
$15.3B
| $699K | ﹤0.01% |
+4,523
| New | +$706K |
|
|
SBXD.U
1271
SilverBox Corp IV Units
SBXD.U
| $699K | ﹤0.01% |
68,725
-100,000
| -59% | -$1.01M |
|
1272
ICF International
ICFI
$1.58B
| $697K | ﹤0.01% |
5,850
+3,570
| +157% | +$534K |
|
1273
GE Vernova
GEV
$247B
| $697K | ﹤0.01% |
2,119
-22,048
| -91% | -$6.89M |
|
1274
Terex
TEX
$7.45B
| $696K | ﹤0.01% |
15,059
-105,210
| -87% | -$5.48M |
|
1275
Northern Oil and Gas
NOG
$2.82B
| $696K | ﹤0.01% |
18,724
+12,347
| +194% | +$484K |
|
Similar funds
Steve Schonfeld's Q4 2024 Portfolio in Review
As of Q4 2024, Steve Schonfeld held 2,528 positions worth $17.2B, up 15% from $15B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Steve Schonfeld deployed $1.86B of net new capital in Q4 2024, opening 540 new positions and adding to 670 existing holdings. Its largest new stake was Invesco MSCI USA ETF: 1,520,000 shares worth $89.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 10% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $144M trimmed.
- Steve Schonfeld's largest Q4 2024 buy was Invesco MSCI USA ETF: 1,520,000 shares worth $89.5M.
- Steve Schonfeld added most to iShares Core S&P 500 ETF in Q4 2024, an estimated $1.67B increase.
- Steve Schonfeld's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $144M.
- Steve Schonfeld fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2024, selling an estimated $40.7M.
- Steve Schonfeld's ten largest holdings make up 36% of its $17.2B portfolio in Q4 2024.
- Steve Schonfeld opened 540 new positions and closed 576 in Q4 2024.
- Steve Schonfeld's portfolio value rose 15% quarter-over-quarter to $17.2B.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.